12:00 AM
 | 
Jun 25, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Eurocine preclinical data

In mice intranasally challenged with pneumococcal bacteria, Eurocine's intranasal pneumococcal glycoconjugate vaccine plus Endocine adjuvant significantly protected mice from infection vs. the vaccine alone. Additionally, Eurocine said the adjuvanted vaccine displayed the same level of protection as...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >